Chenxi Xiang

566 total citations
20 papers, 391 citations indexed

About

Chenxi Xiang is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Chenxi Xiang has authored 20 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Chenxi Xiang's work include Cancer-related molecular mechanisms research (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Chenxi Xiang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Chenxi Xiang collaborates with scholars based in China and United States. Chenxi Xiang's co-authors include Lufeng Zheng, Tao Xi, Xiaoman Li, Qianqian Guo, Lanlan Gao, Haiwei Ni, Yufeng Xia, Zhiting Zhang, Xinwei Guo and Yingying Xing and has published in prestigious journals such as PLoS ONE, Oncogene and The FASEB Journal.

In The Last Decade

Chenxi Xiang

18 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenxi Xiang China 10 285 196 92 58 31 20 391
Ruocen Liao China 9 239 0.8× 139 0.7× 94 1.0× 50 0.9× 18 0.6× 13 348
Liying Geng United States 8 268 0.9× 151 0.8× 107 1.2× 42 0.7× 42 1.4× 9 368
Thomas H. Y. Leung Hong Kong 7 392 1.4× 197 1.0× 93 1.0× 33 0.6× 34 1.1× 7 469
Mar Haz‐Conde Spain 12 391 1.4× 289 1.5× 126 1.4× 39 0.7× 33 1.1× 14 519
Ramona Rudalska Germany 4 351 1.2× 142 0.7× 131 1.4× 71 1.2× 35 1.1× 6 435
Chengdong Qin China 10 358 1.3× 303 1.5× 105 1.1× 52 0.9× 23 0.7× 19 545
Changhao Huang China 12 232 0.8× 128 0.7× 104 1.1× 68 1.2× 23 0.7× 35 389
Ilenia Agliarulo Italy 11 372 1.3× 159 0.8× 75 0.8× 104 1.8× 22 0.7× 12 476
Kefeng Lei China 9 251 0.9× 141 0.7× 75 0.8× 39 0.7× 28 0.9× 20 364
Hexiu Su China 8 281 1.0× 124 0.6× 107 1.2× 64 1.1× 16 0.5× 11 383

Countries citing papers authored by Chenxi Xiang

Since Specialization
Citations

This map shows the geographic impact of Chenxi Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Xiang more than expected).

Fields of papers citing papers by Chenxi Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenxi Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Xiang. The network helps show where Chenxi Xiang may publish in the future.

Co-authorship network of co-authors of Chenxi Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Chenxi Xiang. A scholar is included among the top collaborators of Chenxi Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenxi Xiang. Chenxi Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Qingqing, S. Li, Qianqian Yin, et al.. (2025). VSIG4 as a tumor-associated macrophage marker predicting adverse prognosis in diffuse large B-cell lymphoma. Frontiers in Immunology. 16. 1567035–1567035. 1 indexed citations
2.
3.
Tang, Tingting, Tao Yang, Xiao Liu, et al.. (2024). Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis. Oncogene. 44(9). 601–617. 9 indexed citations
4.
Miao, Xiaodan, et al.. (2024). RUNX3 exerts tumor-suppressive role through inhibiting EXOSC4 expression. Functional & Integrative Genomics. 24(3). 103–103. 2 indexed citations
5.
Liu, Yichen, Ying Chen, Qiong Zhao, et al.. (2023). A positive TGF‐β/miR‐9 regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer. British Journal of Pharmacology. 180(17). 2280–2297. 9 indexed citations
6.
Xu, Yixin, Jing Zhao, Yu Ma, et al.. (2023). The microbiome types of colorectal tissue are potentially associated with the prognosis of patients with colorectal cancer. Frontiers in Microbiology. 14. 1100873–1100873. 16 indexed citations
7.
Xiang, Chenxi, Zhen Wang, Xiaoli Feng, et al.. (2023). Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK- ALCL vs. CD30high PTCL, NOS. Frontiers in Immunology. 14. 1132834–1132834. 4 indexed citations
8.
9.
Ma, Yuanyuan, Jia Liu, Ying Gu, et al.. (2022). Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx. Frontiers in Oncology. 12. 941347–941347. 5 indexed citations
10.
11.
Xiang, Chenxi, Binbin Ji, Bo Wang, et al.. (2021). Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis. Frontiers in Genetics. 12. 756784–756784. 2 indexed citations
12.
Liu, Hui, et al.. (2020). Inhibition of PIM1 attenuates the stem cell–like traits of breast cancer cells by promoting RUNX3 nuclear retention. Journal of Cellular and Molecular Medicine. 24(11). 6308–6323. 11 indexed citations
13.
Liu, Hui, et al.. (2020). Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma. Frontiers in Oncology. 10. 8 indexed citations
14.
Zheng, Lufeng, Qianqian Guo, Chenxi Xiang, et al.. (2019). Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells. Journal of Hematology & Oncology. 12(1). 23–23. 56 indexed citations
15.
Zheng, Lufeng, Chenxi Xiang, Xiaoman Li, et al.. (2018). STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling. Journal of Hematology & Oncology. 11(1). 72–72. 112 indexed citations
16.
Zheng, Lufeng, Zhiting Zhang, Shufang Zhang, et al.. (2018). RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network. Molecular Pharmaceutics. 15(6). 2123–2132. 34 indexed citations
17.
Zheng, Lufeng, Xiaoman Li, Jinjiang Chou, et al.. (2017). StarD13 3’-untranslated region functions as a ceRNA for TP53INP1 in prohibiting migration and invasion of breast cancer cells by regulating miR-125b activity. European Journal of Cell Biology. 97(1). 23–31. 20 indexed citations
18.
Zheng, Lufeng, Meng Xia, Xiaoman Li, et al.. (2017). miR‐125a‐3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor–positive breast cancer. The FASEB Journal. 32(2). 588–600. 49 indexed citations
19.
Guo, Xinwei, Chenxi Xiang, Zhiting Zhang, et al.. (2017). Displacement of Bax by BMF Mediates STARD13 3′UTR-Induced Breast Cancer Cells Apoptosis in an miRNA-Depedent Manner. Molecular Pharmaceutics. 15(1). 63–71. 23 indexed citations
20.
Liao, Gaoyong, et al.. (2015). Effects of phycocyanin on INS-1 pancreatic β-cell mediated by PI3K/Akt/FoxO1 signaling pathway. International Journal of Biological Macromolecules. 83. 185–194. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruocen Liao Breakdown of academic impact, for papers by Liying Geng Breakdown of academic impact, for papers by Thomas H. Y. Leung Breakdown of academic impact, for papers by Mar Haz‐Conde Breakdown of academic impact, for papers by Ramona Rudalska Breakdown of academic impact, for papers by Chengdong Qin Breakdown of academic impact, for papers by Changhao Huang Breakdown of academic impact, for papers by Ilenia Agliarulo Breakdown of academic impact, for papers by Kefeng Lei Breakdown of academic impact, for papers by Hexiu Su
Rankless by CCL
2026